Carcinoma, Hepatocellular
"Carcinoma, Hepatocellular" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
MeSH Number(s)
C04.557.470.200.025.255
C04.588.274.623.160
C06.301.623.160
C06.552.697.160
Concept/Terms
Carcinoma, Hepatocellular- Carcinoma, Hepatocellular
- Carcinomas, Hepatocellular
- Hepatocellular Carcinomas
- Hepatocellular Cancer
- Cancer, Hepatocellular
- Cancers, Hepatocellular
- Hepatocellular Cancers
- Liver Cancer, Adult
- Adult Liver Cancer
- Adult Liver Cancers
- Cancer, Adult Liver
- Cancers, Adult Liver
- Liver Cancers, Adult
- Liver Cell Carcinoma, Adult
- Hepatocellular Carcinoma
- Hepatoma
- Hepatomas
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Hepatocellular".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Hepatocellular".
This graph shows the total number of publications written about "Carcinoma, Hepatocellular" by people in Harvard Catalyst Profiles by year, and whether "Carcinoma, Hepatocellular" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 5 | 9 | 14 |
1995 | 8 | 9 | 17 |
1996 | 9 | 8 | 17 |
1997 | 7 | 3 | 10 |
1998 | 11 | 3 | 14 |
1999 | 15 | 4 | 19 |
2000 | 17 | 6 | 23 |
2001 | 15 | 6 | 21 |
2002 | 24 | 3 | 27 |
2003 | 12 | 7 | 19 |
2004 | 9 | 10 | 19 |
2005 | 13 | 8 | 21 |
2006 | 15 | 7 | 22 |
2007 | 7 | 10 | 17 |
2008 | 26 | 9 | 35 |
2009 | 26 | 7 | 33 |
2010 | 25 | 7 | 32 |
2011 | 36 | 8 | 44 |
2012 | 37 | 8 | 45 |
2013 | 55 | 12 | 67 |
2014 | 56 | 5 | 61 |
2015 | 49 | 6 | 55 |
2016 | 49 | 4 | 53 |
2017 | 59 | 7 | 66 |
2018 | 73 | 5 | 78 |
2019 | 77 | 7 | 84 |
2020 | 78 | 10 | 88 |
2021 | 85 | 7 | 92 |
2022 | 69 | 3 | 72 |
2023 | 60 | 0 | 60 |
2024 | 8 | 0 | 8 |
Below are the most recent publications written about "Carcinoma, Hepatocellular" by people in Profiles.
-
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma. Cancer Res Commun. 2024 Mar 07; 4(3):682-690.
-
Characterizing Metabolic Heterogeneity of Hepatocellular Carcinoma with Hyperpolarized 13C Pyruvate MRI and Mass Spectrometry. Radiol Imaging Cancer. 2024 Mar; 6(2):e230056.
-
Human-scale navigation of magnetic microrobots in hepatic arteries. Sci Robot. 2024 Feb 14; 9(87):eadh8702.
-
[90Y]Yttria Alumino Silicate Glass Microspheres: A Biosimilar Formulation to "TheraSphere" for Cost-Effective Treatment of Liver Cancer. Cancer Biother Radiopharm. 2024 Feb; 39(1):82-91.
-
Defining Minimum Treatment Parameters of Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma: An Expert Consensus. Pract Radiat Oncol. 2024 Mar-Apr; 14(2):134-145.
-
The adverse characteristics of hepatocellular carcinoma in the non-cirrhotic liver disproportionately disadvantage Black patients. Cancer Med. 2024 Feb; 13(3):e6654.
-
Virological, serological and clinical outcomes in chronic hepatitis B virus infection: development and validation of the HEPA-B simulation model. BMJ Open. 2024 01 12; 14(1):e073498.
-
RNF31 promotes proliferation and invasion of hepatocellular carcinoma via nuclear factor kappaB activation. Sci Rep. 2024 01 03; 14(1):346.
-
Immunotherapy, targeted therapy, and their cross talks in hepatocellular carcinoma. Front Immunol. 2023; 14:1285370.
-
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma. Nat Commun. 2023 Dec 14; 14(1):8290.